-
WHY PATIENTS NEED YOU Pfizer's purpose is to deliver breakthroughs that change patients' lives. Research and Development is at the heart of fulfilling Pfizer's purpose as we work to translate advanced science and technologies into the therapies and vaccines that matter most. Whether you are in...
-
degree, preferably in a life science discipline. BS/BA +5 years, MS/MA +3 years, PhD +0 year s of experience in medical writing or related field. Understanding of the role of each member of cross
-
compliance. Provide subject matter expertise and guidance to colleagues. Lead / co-lead complex pilot studies and projects across preclinical Pfizer Oncology enterprise. BASIC QUALIFICATIONS PhD with 4+ years
-
development to support launch and post-launch success. BASIC QUALIFICATIONS Clinically trained (MD, ClinPharm), PharmD, MD-PhD desired Oncology medical professional with strong experience (at least 9 years if
-
PhD in Pharmacometrics, Clinical Pharmacology, Pharmacokinetics, Engineering, Pharmaceutical Sciences, or PharmD Strong written and verbal communication skills PREFERRED QUALIFICATIONS Experience
-
science degree (PhD/PharmD) A minimum of 8 years relevant experience in the pharmaceutical industry Subject matter expertise and experience in Inflammation and Immunology specific therapeutic areas
-
significant findings via internal and external presentations or publications MINIMUM QUALIFICATIONS Recent PhD with 1-3 year post-doctoral experience, MS with 7+ years experience, or BS with 8+ years experience
-
and guide the work of other colleagues to achieve meaningful outcomes and create business impact. Advanced scientific/healthcare degree required (PharmD, PhD, MS, etc.) Minimum 6 years experience in
-
and guide the work of other colleagues to achieve meaningful outcomes and create business impact. Advanced scientific/healthcare degree required (PharmD, PhD, MS, etc.) Minimum 6 years experience in
-
ROLE SUMMARY Pfizer's Oncology Research Unit (ORU) in La Jolla, California, is seeking a Senior Scientist (PhD) focused on translating basic discoveries in the field of cancer epigenetics into novel